| Literature DB >> 36079746 |
Lei Xu1,2, Shini Yang1,2, Kewen Wang1,2, Anjing Lu3, Xue Wang1, Zhenzhen Xu1.
Abstract
The consumption of processed foods has increased compared to that of fresh foods in recent years, especially due to the coronavirus disease 2019 pandemic. Here, we evaluated the health effects of clarified apple juices (CAJs, devoid of pectin and additives) processed to different degrees, including not-from-concentrate (NFC) and from-concentrate (FC) CAJs. A 56-day experiment including a juice-switch after 28 days was designed. An integrated analysis of 16S rRNA sequencing and untargeted metabolomics of cecal content were performed. In addition, differences in the CAJs tested with respect to nutritional indices and composition of small-molecule compounds were analyzed. The NFC CAJ, which showed a higher phenolic content resulting from the lower processing degree, could improve microbiota diversity and influence its structure. It also reduced bile acid and bilirubin contents, as well as inhibited the microbial metabolism of tryptophan in the gut. However, we found that these effects diminished with time by performing experiment extension and undertaking juice-switching. Our study provides evidence regarding the health effects of processed foods that can potentially be applied to public health policy decision making. We believe that NFC juices with a lower processing degree could potentially be healthier than FC juice.Entities:
Keywords: clarified apple juices; food processing degree; gut microbiota; metabolomics; rats
Mesh:
Substances:
Year: 2022 PMID: 36079746 PMCID: PMC9460580 DOI: 10.3390/nu14173488
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Figure 1Schematic diagram of animal experimental scheme.
Basic indices of NFC and FC.
| Index | FC | NFC |
|---|---|---|
| Total phenol (GAE mg/100 mL) | 1073.32 ± 72.33 b | 2169.03 ± 116.84 a |
| pH | 3.57 ± 0.02 b | 3.63 ± 0.02 a |
| Sugar content (°Bx) | 10.83 ± 1.41 a | 10.49 ± 0.11 a |
| Glucose (g/100 mL) | 7.81 ± 0.92 a | 6.13 ± 1.05 b |
| Fructose (g/100 mL) | 4.24 ± 0.79 a | 2.85 ± 0.74 b |
| Sucrose (g/100 mL) | 0.16 ± 0.06 a | 0.10 ± 0.02 a |
| Malic acid (mg/100 mL) | 186.16 ± 2.86 a | 187.10 ± 0.31 a |
| Tartaric acid (mg/100 mL) | 21.33 ± 0.08 a | 18.80 ± 0.15 b |
| Asparagine (mg/100 mL) | 4.57 ± 0.39 a | 10.82 ± 6.58 a |
| Alanine (mg/100 mL) | 4.43 ± 0.39 a | 10.73 ± 6.61 a |
| Serine (mg/100 mL) | 0.69 ± 0.09 a | 1.66 ± 1.08 a |
| Arginine (mg/100 mL) | 0.14 ± 0.02 a | 0.31 ± 0.19 a |
| Glutamine (mg/100 mL) | 0.07 ± 0.01 a | 0.15 ± 0.10 a |
GAE: gallic acid equivalent; Data marked with different letters indicate significant difference of p < 0.05; n = 3.
Figure 2Effect of CAJ on rats: (A) Body weight. (B) Intake amount. (C) Fasting blood glucose. (D) Triglyceride content. (E) Shannon index. (F) Bar plot of gut microbiota on phylum level. (G) PCoA scores plot on OTU level of D28. (H) PCoA scores plot on OTU level of D56. (I) Box plot of F/B ratio. C, control group; AJ, apple juice groups, including NFC and FC groups. * indicates significant difference (p < 0.05) between CAJ and C groups. The “*” means p < 0.05, and “***” means p < 0.001.
Figure 3Effect of NFC and FC CAJs on rats: (A) Shannon index. (B) PCoA scores plot on OTU level. (C) Bar plot of gut microbiota on phylum level. (D) Box plot of Bacteroidota abundance. (E) Box plot of F/B ratio. (F) Cladogram from LEfSe analysis. (G) Correlation heatmap of microbiota and metabolites (The “*” means p < 0.05, and “**” means p < 0.01). (H) Body weight; * indicates significant difference (p < 0.05) between FC and C groups.
Annotation results of differential and their related metabolites from cecal content.
| Class or Name | Formula | C (%) | FC (%) | NFC (%) |
|---|---|---|---|---|
|
| ||||
| Cholic acid | C24H40O5 | 43.32 a | 47.92 a | 8.77 b |
| Deoxycholic acid | C24H40O4 | 48.24 a | 38.52 a | 13.24 b |
| Chenodeoxycholic acid | C24H40O4 | 41.40 a | 39.77 a | 18.83 b |
| Taurocholic acid | C26H45NO7S | 48.19 a | 37.35 a | 14.45 b |
| Lithocholic acid | C24H40O3 | 35.38 a | 35.79 a | 28.83 a |
| 7-Ketodeoxycholic acid | C24H38O5 | 28.33 a,b | 49.52 a | 22.14 b |
| 3-Oxo-4,6-choladienoic acid | C24H34O3 | 34.36 a,b | 43.91 a | 21.73 b |
|
| ||||
| Mesobilirubinogen | C33H44N4O6 | 22.30 b | 60.23 a | 17.47 b |
| D-Urobilinogen | C33H42N4O6 | 21.14 a | 57.88 a | 20.97 b |
| (−)-Stercobilin | C33H46N4O6 | 20.85 b | 49.25 a | 29.90 b |
|
| ||||
| Tryptophan | C11H12N2O2 | 35.46 b | 43.08 a | 21.46 c |
| Indole | C8H7N | 29.30 b | 39.01 a | 31.69 a,b |
| Tryptamine | C10H12N2 | 27.75 a | 29.21 a | 43.04 a |
| Indolecarboxylic acid | C9H7NO2 | 13.77 b | 72.01 a | 14.22 b |
| Indolelactic acid | C10H9NO2 | 34.41 a | 45.44 a | 20.15 b |
| Indolepropionic acid | C11H11NO2 | 29.88 b | 42.13 a | 27.99 b |
| Indoleacrylic acid | C11H9NO2 | 30.13 b | 38.90 a | 30.97 a,b |
| Skatole | C9H9N | 27.00 a | 39.77 a | 33.23 a |
| 3-Methyldioxyindole | C9H9NO2 | 13.77 b | 72.01 a | 14.22 b |
| 5-Hydroxyindoleacetic acid | C10H9NO3 | 49.36 a | 28.60 a,b | 22.05 b |
| Kynurenic acid | C10H7NO3 | 18.87 b | 63.20 a | 17.94 b |
Last three columns show the relative percent contents between the three groups; Different letters indicate significant difference of p < 0.05; n = 6.
Figure 4The effect of NFC and FC CAJ in rats in the prolonged and juice-switch period: (A) Body weight in prolonged period; * (p < 0.05) and ** (p < 0.01) in the first/second indicates significant difference between FC56/NFC56 and C56 groups. (B) Shannon index. (C) PCoA scores plot on OTU level. (D) Body weight in juice-switch period; * indicates the significant difference (p < 0.05) between FC-NFC and C56 groups. (E,F) Heatmaps from hierarchical clustering analysis for differential metabolites on D28 and D56.
Polyphenol compounds of NFC and FC.
| Name | Fold Change (NFC/FC) | VIP | |
|---|---|---|---|
| Chlorogenic acid | 2.21 | 2.96 × 10−7 | 1.19 |
| 5-Methoxysalicylic acid | 46.46 | 5.28 × 10−17 | 2.16 |
| p-Coumaric acid | 18.84 | 3.82 × 10−12 | 2.19 |
| Caffeic acid | 3.32 | 4.94 × 10−6 | 1.44 |
| Ferulic acid | 31.44 | 5.56 × 10−14 | 1.92 |
| Phloretin | 10.21 | 7.02 × 10−7 | 1.53 |
| (+)-Catechin | 16.76 | 1.71 × 10−16 | 2.24 |
| (−)-Epicatechin | 50.53 | 1.04 × 10−16 | 2.40 |
| (−)-gallocatechin | 2.92 | 7.55 × 10−19 | 1.85 |
| Phlorizin | 69.98 | 2.21 × 10−16 | 2.20 |
| Isoquercitrin | 59.83 | 3.96 × 10−11 | 2.09 |
| Rutin | 27.15 | 4.01 × 10−12 | 2.22 |
| Naringenin | 8.52 | 1.84 × 10−9 | 1.42 |
| Eriodictyol | 30.07 | 3.76 × 10−12 | 1.70 |
| (+−)-Taxifolin | 8.05 | 6.21 × 10−13 | 1.64 |
| Quercetin-3-O-galactoside/Hyperoside | 50.38 | 2.19 × 10−12 | 2.07 |
| Procyanidin B1 | 102.51 | 2.84 × 10−16 | 2.51 |
| p-Coumaraldehyde | 67.65 | 2.98 × 10−19 | 2.90 |
VIP: variable importance for projection.